A clinical trial is underway to see if suspended animation, in which the body is cooled to 10–15 °Celsius, could slow patients’ decline and give doctors time to operate.
A novel contrast agent made up of tiny iron oxide nanoparticles can label blood vessels, and highlight adverse events such cerebral ischemia, in dogs and monkeys.